Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debate (English)
- New search for: Berek, Klaus
- New search for: Paganini, Claudia
- New search for: Hegen, Harald
- New search for: Bsteh, Gabriel
- New search for: Grams, Astrid
- New search for: Auer, Michael
- New search for: Berger, Thomas
- New search for: Deisenhammer, Florian
- New search for: Di Pauli, Franziska
- New search for: Berek, Klaus
- New search for: Paganini, Claudia
- New search for: Hegen, Harald
- New search for: Bsteh, Gabriel
- New search for: Grams, Astrid
- New search for: Auer, Michael
- New search for: Berger, Thomas
- New search for: Deisenhammer, Florian
- New search for: Di Pauli, Franziska
In:
Wiener Medizinische Wochenschrift
;
172
, 15-16
; 373-378
;
2022
-
ISSN:
- Article (Journal) / Print
-
Title:Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debate
-
Contributors:Berek, Klaus ( author ) / Paganini, Claudia ( author ) / Hegen, Harald ( author ) / Bsteh, Gabriel ( author ) / Grams, Astrid ( author ) / Auer, Michael ( author ) / Berger, Thomas ( author ) / Deisenhammer, Florian ( author ) / Di Pauli, Franziska ( author )
-
Published in:Wiener Medizinische Wochenschrift ; 172, 15-16 ; 373-378
-
Publisher:
- New search for: Springer Vienna
- New search for: Springer
-
Place of publication:Wien
-
Publication date:2022
-
ISSN:
-
ZDBID:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 44.00 / 44.40
- Further information on Basic classification
- New search for: 560/4202
- New search for: 610.5
- Further information on Dewey Decimal Classification
-
Keywords:
-
Classification:
-
Source:
Table of contents – Volume 172, Issue 15-16
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 327
-
Multiple sclerosis at the crossroads of scientific evidence and clinical translationSellner, Johann et al. | 2022
- 329
-
Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspectsOlbert, Elisabeth / Struhal, Walter et al. | 2022
- 337
-
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activityHegen, Harald / Berek, Klaus / Deisenhammer, Florian et al. | 2022
- 346
-
Experimental laboratory biomarkers in multiple sclerosisArneth, Borros / Kraus, Jörg et al. | 2022
- 359
-
An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosisOvchinnikov, Arkady / Findling, Oliver et al. | 2022
- 365
-
Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safetyMoser, Tobias / Ziemssen, Tjalf / Sellner, Johann et al. | 2022
- 373
-
Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debateBerek, Klaus / Paganini, Claudia / Hegen, Harald / Bsteh, Gabriel / Grams, Astrid / Auer, Michael / Berger, Thomas / Deisenhammer, Florian / Di Pauli, Franziska et al. | 2022
- 379
-
Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean feverTrostel, Constanze / Laichinger, Kornelia / Hauser, Till-Karsten / Saur, Sebastian / Krumbholz, Markus / Henes, Jörg / Ziemann, Ulf / Kowarik, Markus C. et al. | 2021
- 383
-
Neuer Masterstudiengang: Multiple Sklerose ManagementVoigt, Isabel / Stadelmann, Christine / Meuth, Sven G. / Schipp, Bernhard / Flachenecker, Peter / Mäurer, Mathias / Funk, Richard H. W. / Ramisch, Franziska / Niemeier, Joachim / Ziemssen, Tjalf et al. | 2022